⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QURE News
uniQure N.V.
QURE INVESTOR ALERT: uniQure Faces Securities Class Action Over AMT-130 Clinical Trial Design – Hagens Berman
globenewswire.com
QURE
Levi & Korsinsky Notifies Shareholders of uniQure N.V.(QURE) of a Class Action Lawsuit and an Upcoming Deadline
globenewswire.com
QURE
Levi & Korsinsky Notifies Shareholders of uniQure N.V.(QURE) of a Class Action Lawsuit and an Upcoming Deadline
globenewswire.com
QURE
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages uniQure N.V. Investors to Secure Counsel Before Important Deadline in Securities Class Action - QURE
accessnewswire.com
QURE
Portnoy Law Firm Announces Class Action on Behalf of uniQure N.V. Investors
globenewswire.com
QURE
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
QURE
Bronstein, Gewirtz & Grossman LLC Urges uniQure N.V. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
QURE
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Kyndryl Holdings, Inc. (KD), uniQure N.V. (QURE), and REGENXBIO Inc. (RGNX) Announced by Holzer & Holzer, LLC
globenewswire.com
KD
QURE
RGNX
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Kyndryl Holdings, Inc. (KD), uniQure N.V. (QURE), and REGENXBIO Inc. (RGNX) Announced by Holzer & Holzer, LLC
globenewswire.com
KD
QURE
RGNX
Pomerantz LLP Issues Reminder to Shareholders in uniQure N.V. of Class Action – QURE
accessnewswire.com
QURE